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Objective: To evaluate the prevalence of various etiologies of epilepsies and epilepsy
syndromes and to estimate cognitive function in cases of childhood-onset epilepsy.
Methods: A population-based retrospective registry study. We identified all medically
treated children with epilepsy born in 1989–2007 in Finland’s Kuopio University Hospi-
tal catchment area, combining data from the birth registry and the national registry of
special-reimbursement medicines. We reevaluated the epilepsy diagnoses and syn-
dromes and gathered data on etiologies and cognitive impairment.
Results: We identified 289 children with epilepsy. The annual incidence rate of epilep-
sies and epilepsy syndromes was 38 in 100,000, and the misdiagnosis rate was 3%. A
specific etiology was identified in 65% of the cases, with a structural etiology account-
ing for 29% and a genetic or presumed genetic etiology for 32%. Most patients with
unknown-etiology epilepsy had focal epilepsy and were of normal intelligence. Intellec-
tual disability was detected in 35% of cases, and only 17% in this group had an unknown
etiology for the epilepsy. Electroclinical syndromes (mainlyWest syndrome) were rec-
ognized in 35% of the patients.
Significance: Epilepsy is a complex disease that encompasses many etiologies and rare
syndromes. The etiology and specific epilepsy syndrome are important determinants
of the outcome and key factors in treatment selection. Etiological diagnosis can be
achieved for themajority of children and syndromic diagnosis for only a third.
KEYWORDS: Epilepsy, Epilepsy syndrome, Etiology, Prevalence, Childhood, Adoles-
cence, Pediatric, Classification, Cognition, Intelligence.
Epilepsy is one of the most prevalent neurological
diseases worldwide. About 65 million people have epi-
lepsy, roughly 25% of whom are children younger than
15 years of age.1–4 The annual incidence of epilepsy in
children ranges from 33 to 82 in 100,000 persons per
year in developed countries. The incidence is invariably
reported to be highest in the first year of life and falls
to adult levels by the end of the first decade.1,5–7
Recent studies in Finland have found a steady decline
in the incidence of epilepsy in all age groups except
the elderly over the past two decades. This improve-
ment might be due to progress in obstetric and neonatal
care/treatment and an extensive national immunization
program.8–10
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The incidence and prevalence of specific seizure types
and epilepsy syndromes in children are not as well docu-
mented as the incidence of epilepsy.7 Population-based
studies have found a slight predominance of focal seizures
as compared with generalized seizures. Only about a third
of children with epilepsy can be classified as having a speci-
fic epilepsy syndrome.7,11 Though causes of epilepsy are
increasingly being identified, 36–80% of cases still have an
unknown etiology.5,6,12,13 Recent advances in the Interna-
tional League Against Epilepsy (ILAE) classification sys-
tem emphasize the role of evaluating the underlying
neurological cause and etiology of epilepsy in the diagnostic
work-up. Etiology is important, as a major determinant of
treatment, prognosis, and clinical course. Neuroimaging
and genetic advances have improved accuracy levels in
diagnosis of epilepsies.14–17
Cognitive and behavioral comorbidities, including some
degree of intellectual disability, are commonplace in chil-
dren with epilepsy and can have an even greater impact on
quality of life than do seizures.18 Comorbidities influence
language skills, cognitive functioning, and psychosocial
outcomes. With their effects on academic achievements and
professional skills, cognitive abnormalities and difficulties
have a long-lasting impact on children’s lives even after sei-
zures cease. Cognitive disability is the major comorbidity in
these cases.14,19–22 In population-based studies, intellectual
disability has been verified in 20–50% of cases,23,24 and a
Finnish population-based study25 found cognitive function
to be within normal or borderline range for 50%, to show
mild retardation for 22%, and to evidence moderate to sev-
ere retardation in 28%.
The aim for our study was to evaluate the prevalence of
various etiologies of epilepsies and epilepsy syndromes and
to estimate cognitive function in a population-based birth
registry. In previous work, we have published an evaluation
of perinatal and reproductive risk factors for childhood epi-
lepsy in this cohort.26
Materials and Methods
The study population
We analyzed data gathered from the prospective Kuopio
University Hospital (KUH) Birth Registry between January
1, 1989, and December 31, 2007, which corresponded to
total-population births (n = 42,865) (for infants either born
after the 22nd week of pregnancy or weighing 500 g or
more). Stillborn fetuses (n = 193) and neonatal deaths
(death in liveborn within the 28 completed days of life)
(n = 177) were excluded from the analysis. Total popula-
tion of live births was n = 42,495 (Fig. 1).
Kuopio University Hospital is a tertiary-level perinatal
center in eastern Finland and the only delivery hospital in
the North Savo district; hence, the data covered all women
giving birth in the area. Children with a diagnosis of epi-
lepsy were identified from the register of the Social Insur-
ance Institution of Finland, which was linked to the Kuopio
University Birth Registry through children’s unique identi-
fication numbers. The Social Insurance Institution (SII)
maintains a national registry of medicines that are subject to
special reimbursement. A full refund is given for the costs
Figure 1.
Flowchart of the data collection.
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Key Points
• Epilepsy is a complex disease with many etiologies
and rare syndromes
• Mental impairment and subtle intellectual difficulties
exist frequently in epilepsy
• Patient-specific etiology and epilepsy syndrome are
important determinants of the outcome and treatment
selection




of antiepileptic drugs (AEDs), and qualification for this is
based on clinical diagnosis (ICD-10) and a statement pro-
vided in semistructured form by a pediatric neurologist. The
right to receive a full refund for AEDs is granted by the SII
for noninstitutionalized patients. The SII data on full-reim-
bursement AEDs between January 1, 1989, and December
31, 2007, were synthesized with KUH Birth Registry data in
January 2009. We found that 316 of the children received
AEDs for epilepsy linked to refunds. The medical records of
each identified patient were thoroughly reviewed retrospec-
tively for purpose of the current study (by researcher AS).
The clinical factors recorded were onset of seizures, seizure
types and syndromes, etiology of epilepsy, electroen-
cephalograms (EEGs), imaging, and neuropsychology
results. Final classification was performed by two neurolo-
gists (AS and RK).
Definitions
For our research, epilepsy was defined as a disease of the
brain if any of the following conditions were fulfilled: (1) at
least two unprovoked (or reflex) seizures occurred more
than 24 h apart; (2) one unprovoked (or reflex) seizure
occurred and the likelihood of further seizures was similar
to the general recurrence risk (at least 60%) after two unpro-
voked seizures, occurring over the next 10 years; and (3)
there was a diagnosis of epilepsy syndrome.27
We excluded patients with any of the following: (1) febrile
seizures only, (2) neonatal seizures only, (3) single unpro-
voked seizures or acute symptomatic seizures without a need
for further AED treatment, and (4) nonepileptic seizures only.
Seizures were classified as either focal or generalized. The
etiology of the epilepsy was classified as genetic/presumed
genetic, structural, metabolic, immune, infectious, or
unknown, as suggested by the ILAE.28 Specific electroclini-
cal syndromes were identified whenever possible.
Cognitive assessment
The level of cognitive function was categorized as normal
(IQ ≥ 70), mild cognitive impairment (IQ 50–69), moderate
cognitive impairment (IQ 35–49), or severe/profound cog-
nitive impairment (IQ < 34).29 Evaluation was done by
neuropsychological assessment, in case there had been any
doubt of learning difficulties. Neuropsychological assess-
ment was not available for part of the children performing at
normal level, and their evaluation was done on the basis of
review of medical records, including school performance
and everyday adaptive functioning. Also, part of the chil-
dren having profound cognitive impairment were only eval-
uated on the basis of medical records, because they were too
disabled to perform in formal neuropsychological assess-
ment.
Statistical methods
The data management and analysis was performed with
the Statistical Package for the Social Sciences (SPSS),
version 22 (SPSS, Inc., Chicago, IL, U.S.A.). Descriptive
statistics are reported upon here as numbers and/or percent-
ages. Cumulative incidence was calculated by means of the
Kaplan–Meier method via the log-rank test. A chi-squared
test was applied for comparison of cognition between gen-
ders. For all results, p values < 0.05 were considered signif-
icant.
Ethics approval
The study was approved by the Ethics Committee of Kuo-
pio University Hospital. All women giving birth to children
gave informed consent for the collection of study data and
for subsequent use of said data in scientific research, at the
time of data collection. The SII granted permission to link
its data on epilepsy to the birth registry and for use of the
data in this study. Authorization for using the hospital medi-
cal records was granted by the regulatory authority responsi-




The original study population consisted of 316 children.
After reanalysis of all available data from medical records
of the pertinent investigations and from follow-up on the
children, we were able to verify the epilepsy diagnosis of
289 children; reevaluation revealed that 10 (3%) had
nonepileptic seizures, 8 (3%) turned out to have had febrile
seizures only, and 4 (1%) had neonatal seizures. For 5 chil-
dren, there was not enough information for a new analysis
(Fig. 1).
The age at the time of epilepsy diagnosis was median
4.7 years (mean 5.5 years, standard deviation [SD]  0.39,
range 0–19) with no difference evident between sexes
(Fig. 2). Duration of follow-up of the cohort members was
median 13.9 years (mean 14.8 years, SD  5.09 median
13.9 years, range 7.4–26.4). The annual incidence rate was
38 per 100,000, and the cumulative incidence of epilepsy,
0.7%. The figure was highest for those diagnosed before the
age of 12 months, at 141 per 100,000 persons per year.
Seizure types
In 202 patients (70%), seizure onset was focal only,
whereas 53 (18%) had generalized-onset seizures only. Six
(2%) had both focal and generalized-onset seizures. For 28
subjects (10%), including 25 patients with epileptic spasms,
the seizure type could not be classified as focal or general-
ized.
Etiology
The etiology of the epilepsy could be identified in 188
patients, that is, in 65% of cases (Table 1). A genetic or pre-
sumed genetic etiology was identified in 91 cases (32%),
with most being generalized genetic epilepsies. In 12 cases
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(4%), the mother too had epilepsy. Brain MRI was per-
formed for 92% of the patients and brain CT for 5%; thus,
brain imaging was employed for 97% of cases. A structural
etiology was found in 85 patients (29%), for whom perinatal
insult and malformation in cortical and brain development
were the main causes of epilepsy.
Electroclinical syndromes
Electroclinical syndromes were recognized in 35% of the
patients (Table 2). The five main syndromes identified were
West syndrome (25 patients; incidence 60/100,000/year),
benign epilepsy with centrotemporal spikes, childhood and
juvenile absence epilepsy, and juvenile myoclonic epilepsy.
Eight patients developed Lennox-Gastaut syndrome during
the follow-up period.
Intellectual disability
Of the full cohort of 289 children, a psychological assess-
ment was available for 192 children (66%). Ninety-seven
(34%) children were not formally assessed because they
were either too impaired or showed normal school perfor-
mance. Cognitive functioning (Fig. 3) was within the nor-
mal range for 188 of patients (65%). Mild mental
impairment was found in 34 (11%), moderate mental
impairment in 22 (8%), and severe/profound mental impair-
ment in 45 (16%). In addition, 58 (20%) children with nor-
mal cognitive performance had a speech disorder or
learning difficulties that necessitated assistance for aca-
demic achievements. Statistical analysis revealed no differ-
ences between sexes in cognitive functioning.
Table 3 shows the epilepsy syndromes and the etiology
of the epilepsy in the patients with cognitive impairment
(mild, moderate, or severe/profound) (N = 101), account-
ing for 35% of all cases. The main epileptic syndrome asso-
ciated with cognitive impairment was West syndrome, with
25 patients; there were only 1 to 2 patients in each of the
other syndrome groups. For 21 cognitively impaired patients
(21%), the etiology was cortical and brain-development
malformation, when we consider West syndrome patients
among those with structural anomalies. Hypoxic ischemic
encephalopathy existed in 8 children and perinatal insults in
3 (together, 11%). There were 9 cases of cerebral bleeding
or stroke (9%), just 1 of them after the perinatal period, and
there was 1 case of head trauma and 1 near-drowning later
in childhood. There were 17 cases (17%) with unknown
etiology, and most of the remaining cases had a genetic or
presumed genetic reason.
Discussion
Our population-based birth cohort study documented the
prevalence of various epilepsy syndromes and etiologies of
epilepsy in 289 children. It showed that childhood-onset epi-
lepsy does not consist merely of recurrent seizures—there is
a great burden of symptomatic etiology and cognitive impair-
ment. This disease burden affects day-to-day life and casts
independent coping into question for those worst affected.
Our study found the incidence of epilepsy in early child-
hood to be high, with the highest incidence among those
Figure 2.
Distribution of epilepsy diagnosis by age separately for males and
females.
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Table 1. Etiology of epilepsies (N = 289)
Genetic, N = 91 (32%)
Genetic
Chromosomal or gene abnormalities 20
Presumed genetic
Epileptic encephalopathy 5
Generalized genetic epilepsies 39
Focal genetic epilepsy 27
Structural, N = 84 (29%)









Metabolic, N = 4 (1%)
Congenital hyperinsulinism 3
3-methylglutaricaciduria 1





Immunological, N = 0 (0%) 0
Unknown, N = 101 (35%) 101




younger than 12 months old, at 141 per 100,000 per year.
Recent data from Finland10 show a high annual incidence in
infants during the corresponding era in the whole of Finland.
The overall annual incidence of epilepsy in our study was
36 per 100,000 people per year when all other reasons for
antiepileptic treatment were excluded from analysis, a fig-
ure comparable to those found in other population-based
studies: annual incidence of between 33 and 88 cases in
100,000 persons per year. In a similarity to other studies, the
incidence of epilepsy tended to decline in the course of
childhood.7–9 In many studies, the incidence uncovered is
slightly higher in boys,6 but incidence was balanced
between boys and girls in our work.
The misdiagnosis rate was low, at 3%. It was accounted
for by patients who later were diagnosed with nonepileptic
psychogenic events or syncope. In recent review, the preva-
lence of epilepsy misdiagnosis has varied largely between
2% and 70%, depending on the study.30 The low misdiagno-
sis rate found in our work is probably related mostly to the
fact that the case facility, although serving as the area’s pri-
mary specialist diagnostic unit for pediatric neurology, also
has a tertiary epilepsy service with experienced clinical neu-
rophysiologists and full video-EEG service, which can also
be used for diagnostic purposes. Hence, two important com-
mon contributors to the misdiagnosis of epilepsy—namely,
overinterpretation of EEGs and lack of ictal EEGs—have
been largely avoided.
In our study, nearly three-quarters of patients had focal
epilepsy, while less than a fifth had generalized epilepsy
and the rest had mostly epileptic spasms. In general terms,
incidence studies have found focal epilepsy to be more com-
mon in children.5–7
Under the most recent ILAE classification, electroclinical
syndromes were found to constitute a third of childhood epi-
lepsy cases after review of medical records. This is consis-
tent with earlier work.7,11 Most electroclinical syndromes
were rare, but West syndrome had an incidence rate of 59 in
100,000 live births and is slightly higher than the repor-
ted.31We found only one epilepsy constellation, hypothala-
mic hamartoma and gelastic seizures, without any findings
of mesial temporal-lobe epilepsy and hippocampal sclerosis
(<1%).32
Earlier studies have identified a structural etiology for
epilepsy in about 25% of cases.15 In our study, structural
anomalies accounted for roughly 30%, with perinatal
insults, malformation in cortical and brain development,
and head trauma covering the majority. A genetic or pre-
sumed genetic source accounts for another third of the eti-
ologies, and the etiology is unknown in the remaining cases.
It should be noted here that although genetic etiologies can
Table 2. Electroclinical epilepsy syndromes as a first
diagnosis (N = 98)
M F T
Neonatal period
Benign familiar neonatal epilepsy (BNFN) 1 0 1
Early myoclonic encephalopathy (EME) 0 0 0
Ohtahara syndrome 1 0 1
Infancy
Epilepsy of infancy with migrating focal seizures 0 0 0
West syndrome 15 10 25a
Myoclonic epilepsy of infancy (MEI) 3 0 3
Benign infantile epilepsy 2 3 5
Benign familial infantile epilepsy 0 0 0
Dravet syndrome 0 0 0
Myoclonic epilepsy in nonprogressive disorders 0 0 0
Childhood
Genetic febrile seizures plus (GEFS+) 3 1 4
Panayiotopoulos syndrome 0 1 1
Epilepsy with myoclonic atonic seizures (MAE) 0 1 1







Eyelid myoclonia 0 1 1
Epilepsy with myoclonic absences 0 0 0
Lennox-Gastaut syndrome 0 (5) 0 (3) 0 (8)a
Epileptic encephalopathy with
continuous spikes and waves
during sleep (CSWS)
3 1 4
Landau-Kleffner syndrome (LKS) 2 0 2
Childhood absence epilepsy (CAE) 5 8 13
Adolescence–adulthood
Juvenile absence epilepsy (JAE) 2 2 4




Progressive myoclonic epilepsies (PMEs) 1 0 1
Autosomal-dominant epilepsy
with auditory features (ADEAF)
0 0 0
Other familial temporal-lobe epilepsy 0 0 0
Less specific age relationship
Familial focal epilepsy with
variable foci (childhood to adulthood)
0 0 0
Reflex epilepsies 0 0 0
F, female; M, male; T, total number.
Ninety-eight out of 289 patients (34%) had electroclinical epilepsy syn-
drome as a first diagnosis.
aSix West syndrome patients, 1 patient with focal epilepsy, and 1 with
generalized epilepsy and chromosomal anomaly were evaluated as having
Lennox-Gastaut syndrome (in all 8 patients).
Figure 3.
Cognition in childhood-onset epilepsy.
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be clearly defined as chromosomal and gene anomalies, pre-
sumed genetic ones are harder to delineate; the genetic basis
of “idiopathic” epilepsies in general is quite well estab-
lished, but that of focal “idiopathic” epilepsies specifically
is more debatable.7,33
Intellectual disability appears frequently in children with
epilepsy, but alongside these cases are the clear majority:
epileptic children whose cognition is categorized as normal
yet who still face subtle cognitive difficulties that affect
their future achievements.34 In our study, the mental-impair-
ment group accounted for about one-third of all cases, with
the majority in this category having a severe or profound
impairment, as seen in earlier studies. Subtle cognitive diffi-
culties were exhibited by a fifth of the children in this group,
a finding that has emerged also in earlier studies.25 In the
mentally impaired group, West syndrome with multiple eti-
ologies was remarkably frequent. Cortical and brain malfor-
mation was a cause for about one-fifth of the cases in this
group. Other frequent causes of epilepsy and intellectual dis-
ability are antenatal and perinatal problems such as hypoxic
ischemic encephalopathy, other perinatal insults, perinatal
intracerebral bleeding or stroke, and congenital infections.
Treatable conditions such as Glut-1 deficiency (one case)
and congenital hyperinsulinism (three cases) were found in
our study. The etiology was unknown for 2 patients, with
whom there was a strong suspicion of metabolic disorder.
Additional genetic screening might be helpful with respect
to inherited metabolic disorders. In the mental-impairment
group, the etiology was unknown in under a fifth of cases (5
West syndrome patients and 8 focal-epilepsy and develop-
mental-delay patients), while most of the intellectually nor-
mal children—especially in the focal-epilepsy group—had
an unknown etiology. On account of the retrospective nature
of the study, DNA microarray technology was not available
for some of the patients. It is an inescapable conclusion that
further genetic studies are needed, from targeted mutation
analysis to extended genetic screening such as next-generation
sequencing and whole-exome sequencing.35
Strengths and limitations
Being a geographical population, our study population is
representative of the general pediatric epilepsy population.
Table 3. Epilepsy syndromes or the etiology of epilepsy
in the patients with cognitive impairment (mild,
moderate, severe/profound, N = 101)




2 hypoxic ischemic encephalopathies
5 chromosomal anomaly or syndrome
3 tuberous sclerosis complex
5 structural anomalies
1 perinatal insult and 1 congenital
hyperinsulinism 5 unknown etiologies
Myoclonic epilepsy of infancy 1
Genetic febrile seizures plus 1
Epilepsy with myoclonic atonic seizures 1
Eyelid myoclonia 1
Epileptic encephalopathy with
continuous spikes and waves during sleep
2
1 unknown etiology and
1 chromosomal anomaly
Landau-Kleffner syndrome 1
Gelastic seizures with hypothalamic hamartoma 1
Epilepsy with malformations of
cortical and brain development
16





Epilepsy with tumor 1
1 Glioma 1
Epilepsy with infection 4
2 congenital infections
1 meningitis and 1 encephalitis
Epilepsy with trauma 2
1 traumatic brain injury and 1 near-drowning
Epilepsy with perinatal insult 15
2 birth asphyxias
5 hypoxic ischemic
encephalopathies 1 cerebral infarction
7 cases of intracerebral bleeding
Epilepsy with stroke 1
1 case of cerebral bleeding
Epilepsy with metabolic reason 4b
2 cases of congenital hyperinsulinism
1 Glut1-deficiency








1 Angelmann syndrome and
1 Aicardi syndrome
1 Rett syndrome and 1 Masa syndrome
1 Coats syndrome and 1 Sotos syndrome
Focal epilepsy and developmental delay 8
Generalized epilepsy and developmental delay 2
Unclassified epilepsy and epilepsy of unknown etiology 1
Continued
Table 3. Continued.
Epilepsy and epileptic syndromes Number
Total 101
Of all the children with epilepsy, cognitive impairment was seen in 101 out
of 289, or 35%.
aThe West syndrome group includes patients from other groups such as
those with epilepsy with malformation in cortical and brain development,
chromosomal anomalies and syndromes, perinatal insult, and metabolic rea-
sons.
bThe West syndrome group includes one congenital-hyperinsulinism
patient.
cTheWest syndrome group includes one Peho-syndrome patient.




An additional strength is that the retrospective design
allowed us to reevaluate the diagnosis on the basis of all evi-
dence available after follow-up and hence evaluate the mis-
diagnosis rate also.
It is clear, however, that among the children born in the
latter part of the recruitment period, there are still subjects
who are going to receive an epilepsy diagnosis only later
and who therefore are not covered by the study. Accord-
ingly, our incidence figures are accurate for early childhood
and somewhat underestimated for later childhood and ado-
lescence, as compared, for example, with some other earlier
studies from the same area.9,36
At the same time, new etiologies, especially genetic ones,
are being identified constantly, and it is clear from our retro-
spective data that the diagnostic work-up for some of the
patients was done many years ago, and that modern imaging
and molecular diagnostics tools would have revealed more
precise etiologies.
Conclusion
Epilepsy is a complex disease encompassing many etiolo-
gies and rare syndromes. The patient-specific etiology and
epilepsy syndrome are important determinants of the out-
come and treatment selection. Accurate etiological diagno-
sis can be achieved for most children, whereas syndromic
diagnosis is possible for only one-third of them.
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